ELR510444 Inhibits Tumor Growth and Angiogenesis by Abrogating HIF Activity and Disrupting Microtubules in Renal Cell Carcinoma

Quick and Simple Detection Technique to Assess the Binding of Antimicrotubule Agents to the Colchicine-Binding Site

(2010) Sébastien Fortin et al.   BIOLOGICAL PROCEDURES ONLINE

Lucanthone Is a Novel Inhibitor of Autophagy That Induces Cathepsin D-mediated Apoptosis

(2010) Jennifer S. Carew et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Quantitative image analysis identifies pVHL as a key regulator of microtubule dynamic instability

(2010) Claudio R. Thoma et al.   JOURNAL OF CELL BIOLOGY

ELR510444, A Novel Microtubule Disruptor with Multiple Mechanisms of Action

(2010) A. L. Risinger et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

ENMD-1198, a New Analogue of 2-Methoxyestradiol, Displays Both Antiangiogenic and Vascular-Disrupting Properties

(2010) E. Pasquier et al.   MOLECULAR CANCER THERAPEUTICS

Vorinostat Enhances the Activity of Temsirolimus in Renal Cell Carcinoma Through Suppression of Survivin Levels

(2009) D. Mahalingam et al.   CLINICAL CANCER RESEARCH

Targeting both HIF-1 and HIF-2 in human colon cancer cells improves tumor response to sunitinib treatment

(2009) K. Burkitt et al.   MOLECULAR CANCER THERAPEUTICS

Combination Strategy Targeting the Hypoxia Inducible Factor-1  with Mammalian Target of Rapamycin and Histone Deacetylase Inhibitors

(2008) H. M.W. Verheul et al.   CLINICAL CANCER RESEARCH

Anti-Angiogenic Targets in the Treatment of Advanced Renal Cell Carcinoma

(2008) Daniel Heng et al.   CURRENT CANCER DRUG TARGETS